David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Acadia Healthcare
ACHC
$2.78B
| $9.01M | 0.01% |
157,689
-60,278
| -28% | -$3.26M |
|
|
TBI
1327
Trueblue
TBI
$327M
| $8.99M | 0.01% |
408,417
+27,987
| +7% | +$574K |
|
1328
PUT
Macy's
M
$5.94B
| $8.97M | 0.01% |
554,300
-575,500
| -51% | -$8.79M |
|
1329
ARS Pharmaceuticals
SPRY
$569M
| $8.96M | 0.01% |
+205,413
| New | +$9.72M |
|
1330
Coeur Mining
CDE
$22.2B
| $8.93M | 0.01% |
988,534
-168,344
| -15% | -$1.56M |
|
1331
Talphera
TLPH
$63.8M
| $8.92M | 0.01% |
262,444
+217,181
| +480% | +$8.62M |
|
|
JWN
1332
PUT
DELISTED
Nordstrom
JWN
| $8.91M | 0.01% |
235,400
+152,500
| +184% | +$5.64M |
|
|
PRSU
1333
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $8.85M | 0.01% |
211,872
-9,140
| -4% | -$363K |
|
1334
Graco
GGG
$12.7B
| $8.82M | 0.01% |
123,125
+81,120
| +193% | +$5.76M |
|
|
RJET
1335
Republic Airways Holdings
RJET
$897M
| $8.81M | 0.01% |
+43,690
| New | +$6.87M |
|
|
1336
CALL
NVIDIA
NVDA
$5.16T
| $8.81M | 0.01% |
660,000
-10,636,000
| -94% | -$143M |
|
1337
Ubiquiti
UI
$34.9B
| $8.78M | 0.01% |
29,437
+8,850
| +43% | +$2.78M |
|
1338
CALL
iQIYI
IQ
$994M
| $8.76M | 0.01% |
527,300
+163,700
| +45% | +$3.78M |
|
|
WBA
1339
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $8.76M | 0.01% |
159,600
-89,300
| -36% | -$4.41M |
|
1340
Matthews International
MATW
$671M
| $8.75M | 0.01% |
221,324
-93,641
| -30% | -$3.3M |
|
1341
Regenxbio
RGNX
$588M
| $8.74M | 0.01% |
256,225
+110,838
| +76% | +$4.73M |
|
1342
Sprouts Farmers Market
SFM
$8.01B
| $8.74M | 0.01% |
328,183
-434,680
| -57% | -$9.88M |
|
1343
Progress Software
PRGS
$1.78B
| $8.73M | 0.01% |
198,227
-96,755
| -33% | -$4.24M |
|
1344
Sea Limited
SE
$75.4B
| $8.73M | 0.01% |
+39,113
| New | +$9.08M |
|
|
AVLR
1345
DELISTED
Avalara, Inc.
AVLR
| $8.72M | 0.01% |
65,389
-81,094
| -55% | -$12.5M |
|
1346
PUT
Synchrony
SYF
$26.3B
| $8.69M | 0.01% |
213,600
+61,800
| +41% | +$2.38M |
|
1347
CBIZ
CBZ
$2.97B
| $8.68M | 0.01% |
265,744
-18,718
| -7% | -$551K |
|
1348
Terreno Realty
TRNO
$7.45B
| $8.67M | 0.01% |
150,117
+49,531
| +49% | +$2.85M |
|
1349
Emerson Electric
EMR
$86.4B
| $8.67M | 0.01% |
96,063
-423,158
| -81% | -$36.4M |
|
1350
Novavax
NVAX
$1.56B
| $8.63M | 0.01% |
+47,594
| New | +$9.48M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.